Pfizer's answer to Bengt Jarhult: joint challenge to develop methods for discovery of low-frequency adverse effects
Dahl, E.; Lindstrand, G.
Lakartidningen 102(9): 665
2005
ISSN/ISBN: 0023-7205 PMID: 15804040 Document Number: 588515
Document emailed within 1 workday
Related Documents
Baer, D.M.; Belsey, R.E. 1993: Limitations of quality control in physicians' offices and other decentralized testing situations: the challenge to develop new methods of test validation Clinical Chemistry 39(1): 9-12Péré, J.C.; Begaud, B.; Haramburu, F.; Albin, H. 1984: Methods for studying the adverse effects of drugs. I. Comparison of imputability methods: modelling and methodology Therapie 39(3): 279-289
Jämes, D.; Haller, E.; Rosselet, G.; Brooke, E.M.; Schelling, J.L. 1978: Frequency of drug prescriptions and their adverse effects in a medical department Schweizerische Medizinische Wochenschrift 108(33): 1270-1277
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Seydtaghia, F.; De Saussure, P.; Hadengue, A. 2011: High frequency of cutaneous adverse effects under infliximab. Geneva experience, 1999-2008 Revue medicale suisse 7(286): 619-623
Eisenhower, N.D. 2008: One state's answer. Pennsylvania has taken on the challenge of change Modern Healthcare 38(29): 24-25
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Sepúlveda, B. 1970: Adverse effects of contraceptives. II. Adverse effects of contraceptive steroids on the liver Gaceta Medica de Mexico 100(8): 823-831
Tomori, Z. 1981: The adverse effects of smoking and methods of smoking prevention Bratislavske Lekarske Listy 76(3): 374-382
Hesseldahl, K.; McGinley, C.; Monk, G. 2018: Using Design Thinking to Develop New Methods of Inclusive Exhibition Making Studies in Health Technology and Informatics 256: 151-160
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Reimer, A. 2008: The blind alley of Dr Jarhult and health care Lakartidningen 105(9): 652
Sampsel, S.L.; MacLean, C.H.; Pawlson, L.G.; Hudson Scholle, S. 2007: Methods to develop arthritis and osteoporosis measures: a view from the National Committee for Quality Assurance (NCQA) Clinical and Experimental Rheumatology 25(6 Suppl. 47): 22-27
Gutteridge, W.E.; Hudson, A.T.; Jenkins, D.C. 1990: The Wellcome Foundation/World Health Organisation Onchocerciasis Chemotherapy Project Joint Programme to discover and develop a macrofilaricide for onchocerciasis Acta Leidensia 59(1-2): 343-360
Bradshaw, P. 1989: Quest. The challenge of joint validation Nursing Times 85(27): 72-73
González Martínez, L. 1995: Frequency of drug adverse reactions among hospitalized patients Revista Alergia Mexico 42(6): 102-104
Wang, S.F.; Zhan, S.Y. 2016: Active surveillance of adverse drug reaction in the era of big data: challenge and opportunity for control selection Zhonghua Liu Xing Bing Xue Za Zhi 37(7): 909-916